Mortality risk in hemodialysis patients with increased arterial stiffness is reduced by attainment of classical clinical performance measures

American Journal of Nephrology

Volumn 29, Issue 6, 2009, Pages 598-606

  Scholze, Alexandra ^a   Thies, Christina ^b   Cheikhalfraj, Mohamed ^a   Wittstock, Antje ^a   Pommer, Wolfgang ^b   Zidek, Walter ^a   Tepel, Martin ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b VIVANTES HOSPITAL   (Germany)

Author keywords

Arterial stiffness; Clinical performance measures; Hemodialysis

Indexed keywords

SERUM ALBUMIN; UREA;

ADULT; AGED; ARTERIAL STIFFNESS; ARTICLE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; FEMALE; HEMODIALYSIS; HEMOGLOBIN DETERMINATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERFORMANCE MEASUREMENT SYSTEM; PRIORITY JOURNAL; SURVIVAL; TONOMETRY;

AGED; ALBUMINS; ELASTICITY; FEMALE; GERMANY; HEMOGLOBINS; HUMANS; KAPLAN-MEIERS ESTIMATE; KIDNEY FAILURE, CHRONIC; MALE; MANOMETRY; MIDDLE AGED; PROSPECTIVE STUDIES; RADIAL ARTERY; RENAL DIALYSIS; RISK FACTORS;

EID: 58149473581     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000193145     Document Type: Article

References (34)

1. Papagianni A, Dovas S, Bantis C, Belechri AM, Kalovoulos M, Dimitriadis C, Efstratiadis G, Alexopoulos E, Memmos D: Carotid atherosclerosis and endothelial cell adhesion molecules as predictors of long-term outcome in chronic hemodialysis patients. Am J Nephrol 2008;28:265-274.
2. Guerin AP, Blacher J, Pannier B, Marchais SJ, Safar ME, London GM: Impact of aortic stiffness attenuation on survival of patients in end-stage renal failure. Circulation 2001;103:987-992.
3. Mattace-Raso FU, van der Cammen TJ, Hofman A, van Popele NM, Bos ML, Scha lekamp MA, Asmar R, Reneman RS, Hoeks AP, Breteler MM, Witteman JC: Arterial stiffness and risk of coronary heart disease and stroke: the Rotterdam Study. Circulation 2006;113: 657-663.
4. Sutton-Tyrrell K, Najjar SS, Boudreau RM, Venkitachalam L, Kupelian V, Simonsick EM, Havlik R, Lakatta EG, Spurgeon H, Kritchevsky S, Pahor M, Bauer D, Newman A, Health ABC Study: Elevated aortic pulse wave velocity, a marker of arterial stiffness, predicts cardiovascular events in well-functioning older adults. Circulation 2005;111: 3384-3390.
5. Willum-Hansen T, Staessen JA, Torp-Pedersen C, Rasmussen S, Thijs L, Ibsen H, Jeppesen J: Prognostic value of aortic pulse wave velocity as index of arterial stiffness in the general population. Circulation 2006;113: 664-670.
6. Blacher J, Safar ME: Large-artery stiffness, hy pertension and cardiovascula r r isk in older patients. Nat Clin Pract Cardiovasc Med 2005;2: 450-455.
7. Mourad JJ, Pannier B, Blacher J, Rudnichi A, Benetos A, London GM, Safar ME: Creatinine clearance, pulse wave velocity, carotid compliance and essential hypertension. Kidney Int 2001;59:1834-1841.
8. Tetzner F, Scholze A, Wittstock A, Zidek W, Tepel M: Impaired vascular reactivity in patients with chronic kidney disease. Am J Nephrol 2008;28:218-223.
9. Kneifel M, Scholze A, Burkert A, Offermann G, Rothermund L, Zidek W, Tepel M: Impaired renal allograft function is associated with increased arterial stiffness in renal transplant recipients. Am J Transplant 2006;6:1624-1630.
10. Rocco MV, Frankenfield DL, Hopson SD, McClellan WM: Relationship between clinical performance measures and outcomes among patients receiving long-term hemodialysis. Ann Intern Med 2006;145:512-519.
11. KDOQI: KDOQI Clinical Practice Guideline and Clinical Practice Recommendations for anemia in chronic kidney disease: 2007 update of hemoglobin target. Am J Kidney Dis 2007;50:471-530.
12. Mendelssohn DC, Pisoni RL, Arrington CJ, Yeates KE, Leblanc M, Deziel C, Akiba T, Krishnan M, Fukuhara S, Lameire N, Port FK, Wolfe RA: A practice-related risk score (PRS): a DOPPS-derived aggregate quality index for haemodialysis facilities. Nephrol Dial Transplant 2008;23:3227-3233. Doi: 10.1093ndt/gfn195.
13. Wolfe RA, Hubert-Shearon TE, Asby VB, Mahadevan S, Port FK: Improvements in dialysis patient mortality are associated with improvements in urea reduction ratio and hematocrit, 1999 to 2002. Am J Kidney Dis 2004;45: 127-135.
14. Daugirdas JT: Second generation logarithmic estimates of variable volume single-pool Kt/V. J Am Soc Nephrol 1993;4:1205-1212.
15. Finkelstein SM, Cohn JN: First- and third-order models for determining arterial compliance. J Hy pertens 1992;10(s uppl): S11-S14.
16. Cohn JN, Finkelstein S, McVeigh G, Morgan D, LeMay L, Robinson J, Mock J: Noninva-sive pulse wave analysis for the early detection of vascular disease. Hypertension 1995;26:503-508.
17. McVeigh GE, Bratteli CW, Morgan DJ, Alinder CM, Glasser SP, Finkelstein SM, Cohn JN: Age-related abnormalities in arterial compliance identified by pressure pulse contour analysis: aging and arterial compliance. Hyper tension 1999;33: 1392-1398.
18. Resnick LM, Militianu D, Cunnings AJ, Pipe JG, Evelhoch JL, Soulen RL, Lester MA: Pulse waveform analysis of arterial compliance: relation to other techniques, age, and metabolic variables. Am J Hypertens 2000;13:1243-1249.
19. Rietzschel ER, Boeykens E, De Buyzere ML, Duprez DA, Clement DL: A comparison between systolic and diastolic pulse contour analysis in the evaluation of arterial stiffness. Hypertension 2001;37:E15-E22.
20. Arnett DK, Glasser SP, McVeigh G, Prineas R, Finkelstein S, Donahue R, Cohn JN, Sinaiko A: Blood pressure and arterial compliance in young adults: the Minnesota Children's Blood Pressure Study. Am J Hypertens 2001;14: 200-205.
21. Duprez DA, Kaiser DR, Whitwam W, Finkelstein S, Belalcazar A, Patterson R, Glasser S, Cohn JN: Determinants of radial artery pulse wave analysis in asymptomatic individua ls. Am J Hypertens 2004;17:647-653.
22. Cohen DL, Townsend RR: Large and small artery compliance changes during hemodialysis. Am J Hypertens 2002;15:236-239.
23. Scholze A, Maier A, Stocks F, Karamohamad F, Vetter R, Zidek W, Tepel M: Sustained increase of extracellular calcium concentration causes arterial vasoconstriction in humans. J Hypertens 2005;23:2049-2054.
24. Bhuiyan AR, Li S, Li H, Chen W, Srinivasan SR, Berenson GS: Distribution and correlates of arterial compliance measures in asymptomatic young adults: the Bogalusa Heart Study. Am J Hypertens 2005;18:684-691.
25. Glasser SP, Arnett DK, McVeigh GE, Finkelstein SM, Bank AJ, Morgan DJ, Cohn JN: Vascular compliance and cardiovascular disease: a risk factor or a marker? Am J Hypertens 1997;10:1175-1189.
26. Bhuiyan AR, Srinivasan SR, Chen W, Paul TK, Berenson GS: Correlates of vascular structure and function measures in asymptomatic young adults: the Bogalusa Heart Study. At herosclerosis 2006;189:1-7.
27. Owen WF Jr, Lew NL, Liu Y, Lowrie EG, Lazarus JM: The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis. N Engl J Med 1993;329:1001-1006.
28. Ma JZ, Ebben J, Xia H, Collins AJ: Hematocrit level and associated mortality in hemodialysis patients. J Am Soc Nephrol 1999;10: 610-619.
29. Phrommintikul A, Haas SJ, Elsik M, Krum H: Mortality and target haemoglobin concentrations in anaemic patients with chronic kidney disease treated with erythropoietin: a meta-analysis. Lancet 2007;369:381-388.
30. Salahudeen AK, Dykes P, May W: Risk factors for higher mortality at the highest levels of spKt/V in haemodialysis patients. Nephrol Dial Transplant 2003;18:1339-1344.
31. Kilpatrick RD, McAllister CJ, Kovesdy CP, Derose SF, Kopple JD, Kalantar-Zadeh K: Association between serum lipids and survival in hemodialysis patients and impact of race. J Am Soc Nephrol 2007;18:293-303.
32. Tepel M, van der Giet M, Statz M, Jankowski J, Zidek W: The antioxidant acetylcysteine reduces cardiovascular events in patients with end-stage renal failure: a randomized, controlled trial. Circulation 2003;107:992-995.
33. Scholze A, Rinder C, Beige J, Riezler R, Zidek W, Tepel M: Acetylcysteine reduces plasma homocysteine concentration and improves pulse pressure and endothelial function in patients with end-stage renal failure. Circulation 2004;109:369-374.
34. Boaz M, Smetana S, Weinstein T, Matas Z, Gafter U, Iaina A, Knecht A, Weissgarten Y, Brunner D, Fainaru M, Green MS: Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial. Lancet 2000;356:1213-1218.